We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Everock Inc (CE) | USOTC:EVRN | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 00:00:00 |
Everock, Inc. (PINKSHEETS: EVRN) engages in the design, production, and distribution of natural gourmet products in the United States. The company provides vegetable dips and sandwich spreads under the Nature's Peak brand name. Its product line includes VeggieSpread and VeggieDip products, which are offered in various flavors. The company serves restaurants, delis, cafeterias, and club stores. It offers its products through natural food stores and specialty grocery chains. Get the delicious details at the link: http://bit.ly/REPORT-EVRN
American Petro-Hunter, Inc. (OTCQB: AAPH) is an oil and natural gas exploration and production company with current projects in Payne and Lincoln Counties in Oklahoma. In 2012, oil sales from our producing wells averaged 13.1 cumulative barrels per day. AAPH has entered into a stock purchase agreement and released form 10-Q. Get a full report at the following link: http://bit.ly/REPORT-AAPH
Sigma labs, Inc. (OTCQB: SGLB) develops precision manufacturing solutions and advanced materials technologies, as well as R&D solutions for first-tier integrators and other commercial firms worldwide. Sigma Labs has current contracts with Federal government and private industry clients to provide high-level consultants and develop technologies from their conception through the design, building, and testing of prototype systems. Get the full report: http://bit.ly/REPORT-SGLB
Apricus Biosciences, Inc. (NASDAQ: APRI) is a pharmaceutical company that develops innovative treatments including male and female sexual health. The Company has one approved product, Vitaros, for the treatment of erectile dysfunction, which is now approved in Europe and Canada and will be commercialized by Apricus Bio's marketing partners, which include Abbott Laboratories Limited, Takeda Pharmaceuticals International GmbH, Hexal AG (Sandoz), and Bracco SpA. Femprox, the Company's product candidate for the treatment of female sexual interest and arousal disorder, has successfully completed a nearly 400-subject proof-of-concept study. Get updates on Vitaros and a full report at this link: http://bit.ly/REPORT-APRI
Get our small and micro-cap alerts in real time by joining our SMS alerts send “OTCBBAlerts” to 25827 or join our limited time free VIP membership at http://www.OtcbbJournal.com
Please note* that all media from Small-Cap Specialists LLC/OtcbbJournal.com is permission based. The companies mentioned in this media release have provided documented permission to Small-Cap Specialists to use their company names and public ticker symbols for IR purposes. In some cases Small-Cap Specialists Issues Research without company permission as investment opinion. Small-Cap Specialists employees are not registered as an Investment Adviser in any jurisdiction whatsoever. This advertisement is for informational purposes only and is not intended to be a recommendation to buy or sell securities in any of the above mentioned companies. SCS LLC has NOT been compensated for the mention of any of the companies in this press release.
Contact: SmallCapSpecialists@gmail.com
Mark Bonacci, Chief Editor
1 Year Everock (CE) Chart |
1 Month Everock (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions